3 ms·
The CDC has a strong reputation and this would be a rare disappointment. I think they still deserve benefit of the doubt for now but also owe the public a clea
by divbzero 7y ago
The CDC has a strong reputation and this would be a rare disappointment.
I think they still deserve benefit of the doubt for now but also owe the public a clear explanation, especially when professional epidemiologists are also puzzled by the situation.
The misstep if true would be particularly regretful for a couple reasons. First, the underlying technology isn’t complicated: PCR [1] is for molecular biology what the hash map might be for software engineering, not simple per se but well understood and widely used. The coronavirus test requires a variation to detect RNA instead of DNA [2] but that still isn’t rocket science. Second, the article points to alternative tests [3] that could probably have been performed safely by many labs in the US if they had the approval.
[1]: https://en.wikipedia.org/wiki/Polymerase_chain_reaction https://en.wikipedia.org/wiki/Polymerase_chain_reaction
[2]: https://en.wikipedia.org/wiki/Reverse_transcription_polymerase_chain_reaction https://en.wikipedia.org/wiki/Reverse_transcription_polymera...
[3]: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance https://www.who.int/emergencies/diseases/novel-coronavirus-2...
(Edit: It should be noted that PCR can be finicky. But given that labs around the world have been sharing which primers they use, I would hope that the CDC had access to that information, could test those primers in parallel, and pick the ones that performed the best.)
- koheripbal 7y agoIt's impossible to argue that there wasn't a misstep here. They test kits were recalled, and they simultaneously banned states from developing their own local tests - something multiple other countries were able to do with ease. A PCR test is one of the simplest tests a lab can perform, and while there's some value in centralizing tests - it's ridiculous to tie the hands of local labs while simultaneously stalling the central test kits. Whenever possible, in massive nation-wide problems like this, we need multiple teams working in parallel. We cannot afford single points of failure like this. The same is true for vaccine development.